Krystal Biotech to Present at Cantor Global Healthcare Conference 2025

Rhea-AI Summary

Krystal Biotech (NASDAQ:KRYS) announced its participation in the upcoming Cantor Global Healthcare Conference 2025, taking place in New York on September 4, 2025. Chairman and CEO Krish S. Krishnan will participate in a fireside chat at 10:20 AM ET and conduct investor meetings throughout the day.

The presentation will be accessible via webcast and will be made available on the Investors section of the company's website.

PITTSBURGH, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:20 am ET and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 10:20 am ET on Thursday, September 4, 2025 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®, the Company’s first commercial product, is the first-ever redosable gene therapy, and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:                                                                                        
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com                                                                                   

FAQ

When is Krystal Biotech (KRYS) presenting at the Cantor Global Healthcare Conference 2025?

Krystal Biotech will present at 10:20 AM ET on September 4, 2025 in New York.

Who will represent Krystal Biotech (KRYS) at the Cantor Healthcare Conference?

Krish S. Krishnan, the Chairman and Chief Executive Officer of Krystal Biotech, will represent the company.

How can investors access Krystal Biotech's (KRYS) presentation at the Cantor Conference?

The presentation will be available via webcast starting at 10:20 AM ET and will be accessible through the Investors section of Krystal Biotech's website.

What type of presentation will Krystal Biotech (KRYS) give at the Cantor Conference?

Krystal Biotech's CEO will participate in a fireside chat and host investor meetings throughout the day.